Market News

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries today announced it will release second quarter financial results after the market closes on Wednesday, August 3, 2022.

A conference call and audio webcast will also be held on Wednesday, August 3, 2022, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.

Participants may pre-register for the live conference call any time prior to the start of the call by navigating to https://dpregister.com/sreg/10167739/f30fcc46b0 and entering their contact information. You will then receive a personalized phone number and PIN to dial into the live conference call.

About Green Thumb Industries

Green Thumb Industries Inc. ("Green Thumb"), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 77 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 4,000 people and serves millions of patients and customers each year. The company was named to Crain's Chicago Business, Fast 50 list in 2021 and 2022 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available at www.GTIgrows.com .

Investor Contact:

Media Contact:

Andy Grossman Leah Rosenfeld
EVP, Capital Markets & Investor Relations Senior Director, External Communications
InvestorRelations@gtigrows.com media@gtigrows.com
310-622-8257 847-951-5324

Source: Green Thumb Industries


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GTII:CNX,GTBIF
Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada

Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada

Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company focused on processing, product development, sales, organoleptic testing and analytical testing, is pleased to announce it has received its Medical Sales License from Health Canada which now authorizes Adastra to sell cannabinoid-containing products that are formulated for and distributed to the medical cannabis market

With its Medical Sales License, Adastra is now authorized to:

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Cresco Labs Announces Second Quarter 2022 Results

Company reports 4% year-over-year revenue growth and 11% year-over-year adjusted EBITDA growth; continues industry leadership with branded product performance and retail productivity

Company provides positive update on Columbia Care divestiture process, regulatory approvals and closing timeline

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Marijuana Dispensary in Auburndale

New dispensary expands patient access to medical cannabis; grand opening specials available

9 p.m. from Monday through Saturday and 10 a.m8 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Hygrovest

HGV Investment Portfolio Report July 2022

HGV Limited (ASX: HGV) ("HGV”)is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.

Keep reading...Show less
VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

It’s been a seriously difficult period for Canadian cannabis operators over the past few years, with volatility prevailing as the status quo for companies in the market.

Charlie Bowman, president and CEO of HEXO (NASDAQ:HEXO,TSX:HEXO), understands that, and that’s why his first order of business after taking the helm at the company was to clean up its finances. He sees a better path ahead for HEXO now that it has restructured its assets and had its debt purchased by a fellow Canadian producer.

Bowman spoke at length with the Investing News Network (INN) about the downturn in Canadian cannabis stocks, HEXO’s NASDAQ listing status and its partnership with Tilray Brands (NASDAQ:TLRY,TSX:TLRY).

Keep reading...Show less
Avicanna Reports Q2 2022 Financial Statement

Avicanna Reports Q2 2022 Financial Statement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS

Avicanna Inc. (" Avicanna " or the " Company ") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce the filing of its interim financial statements for the three-month period ending June 30, 2022 (" Q2 2022 ").

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×